Company intelligence / Profile preview
Trimel Pharmaceuticals
Mississauga, Ontario, Canadatrimelpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Natesto (testosterone nasal gel), formerly CompleoTRT, received FDA approval in May 2014 for testosterone replacement therapy in adult males with hypogonadism. The product offers a novel intranasal route that avoids transference risks associated with topical gels. Other pipeline products included Tefina™ for female orgasmic disorder and various respiratory therapies. Clinical results showed efficacy and safety endpoints were met for Natesto; other programs were at earlier stages or discontinued after rebranding to Acerus[3].
- Therapeutic areas
- NeurologyPsychiatryPulmonologyMen's HealthWomen's Health
- Modalities
- Small moleculeHormoneNasal gel drug delivery system
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Endo International plc—exclusive license agreement for marketing NATESTO in US/Mexico ($25M upfront + milestones)Aytu BioPharma—distribution/commercialization partnership post-Acerus transition
Beyond the preview
Go deeper on Trimel Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trimel Pharmaceuticals.